Drugs / SA 14-14-2 JE vaccine
SA 14-14-2 JE vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01635816 Comparator | May → Dec 2012 | — | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SA 14-14-2 JE vaccine | “We conducted a four-arm, double-blind, randomized controlled trial among 818 Bangladeshi infants between 10 and 12 months of age to establish equivalence among three lots of...” PMID 25239483 ↗ Sep 2014 |
| Known as | Japanese encephalitis live attenuated SA 14-14-2 vaccine | “Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Manufactured in a New Good Manufacturing Practices Facility and Non-inferiority With Respect to an Earlier Product.” NCT01635816 ↗ |
| Known as | JE live attenuated SA 14-14-2 vaccine | “JE live attenuated SA 14-14-2 vaccine has been used in Asia for more than two decades in over 400 million children.” NCT01635816 ↗ |